CureVac’s Covid Vaccine Performed Badly in Trial, In Part Due to Variants

AAM 16:05 Carl Zimmer, NYT > Top Stories

NYT > Top Stories Carl ZimmerThe results were a blow to hopes that the vaccine could help meet the world’s urgent need. “This is pretty devastating” for the company, one expert said. June 16, 2021 at 11:25PM https://ift.tt/3iRcv0T